Your browser doesn't support javascript.
loading
Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.
Huang, Huarong; Cui, Xiao-Xing; Chen, Shaohua; Goodin, Susan; Liu, Yue; He, Yan; Li, Dongli; Wang, Hong; Van Doren, Jeremiah; Dipaola, Robert S; Conney, Allan H; Zheng, Xi.
Affiliation
  • Huang H; Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou, P.R. China.
  • Cui XX; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, U.S.A.
  • Chen S; Guangdong Provincial People's Hospital, Guangzhou, P.R. China.
  • Goodin S; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, U.S.A.
  • Liu Y; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, U.S.A.
  • He Y; Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou, P.R. China.
  • Li D; Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou, P.R. China.
  • Wang H; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, U.S.A.
  • Van Doren J; Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, U.S.A.
  • Dipaola RS; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, U.S.A.
  • Conney AH; Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou, P.R. China Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, U.S.A.
  • Zheng X; Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou, P.R. China Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, U.S.A. xizh
Anticancer Res ; 34(7): 3357-63, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24982340
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Pyrazoles / Pyrroles / Sulfonamides / Antineoplastic Combined Chemotherapy Protocols / Heptanoic Acids Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Anticancer Res Year: 2014 Document type: Article Country of publication: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Pyrazoles / Pyrroles / Sulfonamides / Antineoplastic Combined Chemotherapy Protocols / Heptanoic Acids Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Anticancer Res Year: 2014 Document type: Article Country of publication: Greece